Research And Markets Research And Markets
0 CHECKOUT

Liver Cancer Drug Pipeline Update

  • ID: 1197059
  • August 2016
  • Region: Global
  • Bioseeker
1 of 2

There are today 260 companies plus partners developing 280 drugs targeting liver cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 65 drugs. Liver Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 221 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 213 out of the 213 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 56 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.

Drug Pipeline Update at a Glance

Investigators
Includes more than 260 principal companies plus their collaborators. There is direct access from inside the application to web pages of all principal companies.

Note: You are able to sort READ MORE >

Note: Product cover images may vary from those shown
2 of 2



Delivery Format: Desktop App plus Online Access to Updates (One Year)

Note: Product cover images may vary from those shown
3 of 2
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db